Product Images Methylphenidate Hydrochloride Extended-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Methylphenidate Hydrochloride Extended-release NDC 0406-0136 by Specgx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - methylphenidate hydrochloride er tablets 1
This appears to be a chemical compound description. The compound is labeled as Ox OCHs and has a molecular weight of 269.77 g/mol. Further information about this compound is not available.*
Figure 1 - methylphenidate hydrochloride er tablets 2
This is a table showing the mean plasma methylphenidate concentration in ng/mL for two different dosage regimens of methylphenidate HCl extended-release tablets, one being 18mg once daily and the other being 5mg three times daily.*
Figure 2 - methylphenidate hydrochloride er tablets 3
Figure 3 - methylphenidate hydrochloride er tablets 4
This is a table providing information on the effects of Methylphenidate Hydrochloride Extended-Release Tablets and Placebo on the Combined Attention Subscale. The table shows the results for two groups of participants at various hours post initial dosage. The values are presented in mean and mean plus standard error of the mean.*
PRINCIPAL DISPLAY PANEL - 27 mg Bottle - methylphenidate hydrochloride er tablets 5
NDC 0406-0127-01 is a medication in the form of 100 tablets, each containing Methylphenidate Hydrochloride USP 27 mg in an extended-release formulation. The usual dosage is once daily, and it should be stored at controlled room temperature, protected from humidity. Pharmacists should dispense the medication guide and provide individual patient instructions. The medication is distributed by Mallinckrodt in the USA.*
PRINCIPAL DISPLAY PANEL - 36 mg Bottle - methylphenidate hydrochloride er tablets 6
This is a medication description for NDC 0406-0136-01 tablets containing Methylphenidate hydrochloride USP in an extended-release formulation. The usual dosage is once daily, and the tablets should be protected from humidity and dispensed in tight, light-resistant containers. The medication guide should be provided to each patient. The address of the manufacturer is also included.*
PRINCIPAL DISPLAY PANEL - 54 mg Bottle - methylphenidate hydrochloride er tablets 7
NDC 0406-0154-01 is a medication that comes in a package of 100 tablets, each containing Methylphenidate Hydrochloride USP 54mg. It is an extended-release tablet used for treating hyperactivity/Attention Deficit Disorder (ADHD). The tablets should be stored between 20 to 25°C (68° to 77°F) or 30°C (59° to 86°F). The label warns that the medication should be kept protected from moisture in a tightly sealed container. The medication guide should be dispensed with the drug, and this drug should be dispensed only with a child-resistant cap to prevent accidental ingestion. The manufacturer of the medication is Mallinckrodt Pharmaceuticals.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.